ID

12899

Descripción

Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00136422

Link

https://clinicaltrials.gov/show/NCT00136422

Palabras clave

Versiones (1)
  1. 5/1/16 5/1/16 -
Subido en

5 de enero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Acute Myelogenous Leukemia NCT00136422

Inglés

Eligibility Acute Myelogenous Leukemia NCT00136422

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients must have pathologically documented myelodysplasia or acute myelogenous leukemia.
Descripción

myelodysplastic syndrome, myeloid leukemia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3463824
UMLS CUI [2]
C0023467
the patients with myelodysplasia must also have: french-american-british (fab) subtype refractory anemia with excess blasts (raeb) or refractory anemia with excess blasts in transformation (raeb-t), or normal or hypercellular bone marrow.
Descripción

inclusion myelodysplastic syndrome

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3463824
UMLS CUI [1,2]
C1512693
UMLS CUI [2]
C2984084
UMLS CUI [3]
C0005953
the patients with acute myelogenous leukemia must also: not be candidates for myelosuppressive chemotherapy due to age or comorbid disease, or have relapsed acute myelogenous leukemia or be refractory to standard therapy and not likely to require cytoreductive therapy within 60 days
Descripción

inclusion acute myelogenous leukemia

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C1512693
UMLS CUI [2]
C0392920
UMLS CUI [3]
C0277556
UMLS CUI [4]
C0205269
eastern cooperative oncology group (ecog) performance status 0 or 1.
Descripción

ecog performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
estimated life expectancy of 6 months or greater.
Descripción

life expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
age at least 18 years.
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
greater than 4 weeks from any chemotherapy, radiotherapy, immunotherapy, or systemic glucocorticoid therapy (non-glucocorticoid hormonal therapy allowed).
Descripción

therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0087111
greater than 2 months following bone marrow or peripheral blood stem cell transplantation or treatment with donor lymphocyte infusion (dli).
Descripción

stem cell transplant, dli

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1504389
UMLS CUI [2]
C1512034
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
uncontrolled active infection.
Descripción

comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0517627
pregnancy or nursing mothers.
Descripción

pregnancy, breastfeeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
previous participation in an adenovirus based trial.
Descripción

study subject participation status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
the patients with myelodysplasia who have either: fab subtype refractory anemia (ra), refractory anemia with ringed sideroblasts (rars), chronic myelomonocytic leukemia (cmml), or the presence of hypocellular bone marrow.
Descripción

exclusion myelodysplastic syndrome

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C3463824
UMLS CUI [2]
C2984084
UMLS CUI [3]
C0005953
chemotherapy, radiotherapy, immunotherapy, or systemic steroid therapy within the last 4 weeks.
Descripción

therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C1522449
UMLS CUI [3]
C0021083
UMLS CUI [4]
C0038317
active central nervous system (cns) disease.
Descripción

comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0007682
evidence of infection with the human immunodeficiency virus.
Descripción

comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0019682
active psychiatric or mental illness making informed consent or careful clinical follow-up unlikely.
Descripción

comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0004936
Volver a la parte superior de la página

Similar models

Eligibility Acute Myelogenous Leukemia NCT00136422

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
myelodysplastic syndrome, myeloid leukemia
Item
patients must have pathologically documented myelodysplasia or acute myelogenous leukemia.
boolean
C3463824 (UMLS CUI [1])
C0023467 (UMLS CUI [2])
inclusion myelodysplastic syndrome
Item
the patients with myelodysplasia must also have: french-american-british (fab) subtype refractory anemia with excess blasts (raeb) or refractory anemia with excess blasts in transformation (raeb-t), or normal or hypercellular bone marrow.
boolean
C3463824 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
C2984084 (UMLS CUI [2])
C0005953 (UMLS CUI [3])
inclusion acute myelogenous leukemia
Item
the patients with acute myelogenous leukemia must also: not be candidates for myelosuppressive chemotherapy due to age or comorbid disease, or have relapsed acute myelogenous leukemia or be refractory to standard therapy and not likely to require cytoreductive therapy within 60 days
boolean
C0023467 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2])
C0277556 (UMLS CUI [3])
C0205269 (UMLS CUI [4])
ecog performance status
Item
eastern cooperative oncology group (ecog) performance status 0 or 1.
boolean
C1520224 (UMLS CUI [1])
life expectancy
Item
estimated life expectancy of 6 months or greater.
boolean
C0023671 (UMLS CUI [1])
age
Item
age at least 18 years.
boolean
C0001779 (UMLS CUI [1])
therapy
Item
greater than 4 weeks from any chemotherapy, radiotherapy, immunotherapy, or systemic glucocorticoid therapy (non-glucocorticoid hormonal therapy allowed).
boolean
C0087111 (UMLS CUI [1])
stem cell transplant, dli
Item
greater than 2 months following bone marrow or peripheral blood stem cell transplantation or treatment with donor lymphocyte infusion (dli).
boolean
C1504389 (UMLS CUI [1])
C1512034 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
comorbidity
Item
uncontrolled active infection.
boolean
C0009488 (UMLS CUI [1,1])
C0517627 (UMLS CUI [1,2])
pregnancy, breastfeeding
Item
pregnancy or nursing mothers.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
study subject participation status
Item
previous participation in an adenovirus based trial.
boolean
C2348568 (UMLS CUI [1])
exclusion myelodysplastic syndrome
Item
the patients with myelodysplasia who have either: fab subtype refractory anemia (ra), refractory anemia with ringed sideroblasts (rars), chronic myelomonocytic leukemia (cmml), or the presence of hypocellular bone marrow.
boolean
C0680251 (UMLS CUI [1,1])
C3463824 (UMLS CUI [1,2])
C2984084 (UMLS CUI [2])
C0005953 (UMLS CUI [3])
therapy
Item
chemotherapy, radiotherapy, immunotherapy, or systemic steroid therapy within the last 4 weeks.
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
C0038317 (UMLS CUI [4])
comorbidity
Item
active central nervous system (cns) disease.
boolean
C0009488 (UMLS CUI [1,1])
C0007682 (UMLS CUI [1,2])
comorbidity
Item
evidence of infection with the human immunodeficiency virus.
boolean
C0009488 (UMLS CUI [1,1])
C0019682 (UMLS CUI [1,2])
comorbidity
Item
active psychiatric or mental illness making informed consent or careful clinical follow-up unlikely.
boolean
C0009488 (UMLS CUI [1,1])
C0004936 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial